Alleanza Dolore

Survey — Chronic pain · Results

Your experience has spoken.

1,267 people told us about their lives with chronic pain. The data collected, anonymous and aggregated, has become a tool for advocacy with institutions.

1,267questionnaires collected out of 10 million Italians living with chronic pain

Every story counted

All answers carry equal weight, from people in pain for 2 months to those who have lived with it for 20 years.

Data that changes things

The Alliance takes the aggregated results to ministerial and regional decision-making tables.

Anonymous and secure

No personally identifiable data. Only patients' experience, protected in line with the GDPR.

The research · Methodology and partners

How this research came about

A participatory assessment process that turns patients' subjective experience into structured scientific evidence.

Powered by

HE Survey
Read the full methodology

The data analysis presented in this report is the result of a rigorous participatory assessment process, designed to turn patients' subjective experience into structured scientific evidence. The methodology combines advanced technology with multidisciplinary analytical expertise, both needed to tackle the complexity of chronic pain.

The technology behind the survey is the HE Survey platform, conceived and developed by Health Engine, specifically by Luca Savarese and Maurizio Vella, which enabled wide-reaching data collection and a scientific analysis of the patient experience. The interpretation of the results rests on a classification system and analytical taxonomy devised by Health Engine with the valuable collaboration of Lorenzo Latella, whose contribution made it possible to standardise the conditions and impacts reported, making the data comparable and consistent with international clinical standards.

The research was coordinated by a multidisciplinary team combining project management, advocacy and data analysis. This structure not only ensured the information was collected, but also that the research design faithfully reflected the needs expressed directly by patient associations, laying the foundations for advocacy based on real value and empirical evidence.

With the support of

  • Insightec
  • Medtronic
  • Theras
  • SOL
  • Abbott
  • Boston Scientific

Survey results

Living with chronic pain: the weight no one sees

An unprecedented picture of the impact of chronic pain on life, work and Italian society, built from the answers of those who live with it every day.

1,267Questionnaires collectedOut of an estimated 10 million Italians living with chronic pain.
12Associations involvedThe coalition's organisations distributed the survey through their networks.
20/20Italian regionsNationwide coverage giving a voice to people in pain across the country.
2Question formatsNRS 0–10 scale and multiple choice, referring to the last 4 weeks.

Methodological note. The survey is aimed at people living with chronic pain — pain present for at least 3 months — regardless of diagnosis. Unless stated otherwise, answers refer to the last 4 weeks. The data is anonymous and aggregated and was collected and analysed with the HE Survey platform, a non-profit, impartial initiative serving patient associations.

Data analysis

Pain can be seen

The questionnaires reveal a path of delays, gaps in treatment and an impact that goes beyond the home to weigh on work and society.

12 associations. All 20 regions. A sample that, for the first time, gives a voice to those who suffer in silence.

Section 01 · The sample

A clear profile

83%of respondents are women1,052 women out of 1,267 · 213 men (17%).
75%have lived with pain for over 5 years
46–60the most represented age group
28%waited over 5 years for a diagnosis
60%describe their pain as constant

Conditions often diagnosed late

The sample is 83% female, and the most cited conditions are chronic diseases with a high prevalence among women, historically recognised years late.

74% say pain has changed their sex life and intimacy.

Most cited conditions · number of mentions
Fibromyalgia261
Migraine / headache158
Endometriosis / adenomyosis103
Psoriatic arthritis89
Rheumatoid arthritis / spondyloarthritis57 + 49

Section 02 · Impact on health care

57% have never been offered a structured pain care pathway. 718 people out of 1,267. In most cases there is a single reason: no doctor ever suggested it.

A significant treatment gap

Drug treatment dominates, but an alarming share of patients receive no active treatment at all.

59%

Drug treatment dominates

45% drugs only, 14% combined therapy

34%

Treatment gap

23% never started it, 11% stopped

7%

Minority alternatives

5% non-drug, 2% devices

Diagnostic delay

The most frequent answer to the time between first symptoms and diagnosis is “more than 5 years”. A very large part of the sample lived with undiagnosed symptoms for a long time.

350respondents waited over 5 yearsBy far the largest group.
Time from symptoms to diagnosis · number of respondents
More than 5 years350
1–3 years227
Less than 6 months218
6 months – 1 year209
3–5 years101

Care pathways are largely missing

Most patients are left to manage their condition without structured guidance: a fragmented, reactive approach rather than a strategic one.

Only 21% (266 people) are currently in a care pathway. For everyone else it is the exception, not the rule.

In a structured care pathway? · number of respondents
No, never offered718 · 57%
Yes, currently266 · 21%
Yes, in the past128 · 10%
Don't know84 · 7%

Section 03 · Social impact and consequences

How much it hurts: pain intensity

At its worst, almost 3 in 4 people experience pain between 8 and 10 out of 10. For 60% the pain is constant: not an occasional crisis, but everyday life.

72%experience pain of 8–10 at its worst
6–8average intensity over the last 4 weeks

The emotional sphere is the epicentre

Where the impact is most severe (scores 8–10): fatigue and the emotional burden outweigh purely physical limitations.

Physical and mental fatigue69%
Anxiety about the future59%
Sleep and rest58%
Frustration / helplessness55%
Physical activity and hobbies52%
Isolation / not being understood49%

Pain reduces work

29%have reduced their working hoursScaled to 10 million: 2.9 million workers.
27%have given up career opportunities
40%limit leisure and social activities
5%have a family member who reduced their work
6%are on sick leave or disability

What it means for the State

Scaled to 10 million Italians · illustrative estimate based on reported values.

€72bnestimated system cost every yearLost tax revenue €12.4bn + private spending €12.1bn + productivity loss ~€47bn.
Gross income not earned
€28.9bn
Lost revenue (income tax + contributions)
€12.4bn
Total private spending
€12.1bn
Productivity loss (presenteeism)
~€47bn

Calculation assumptions

  • 29% reduce hours + 5% family member = 3.44 million workers
  • Average gross salary: €28,000/year
  • Income loss: 30% of salary
  • Income tax (IRPEF) + contributions rate: 43%
  • Presenteeism: reduced efficiency among those in work

From evidence to action

What can be done

Health system and institutions

  • Define care pathways (PDTA) for chronic pain and shorten diagnostic times
  • Train doctors to refer patients proactively to pain centres
  • Include psychological support in the essential levels of care (LEA) as standard
  • Recognise the hidden cost: €12.4bn in lost tax revenue

Associations and civil society

  • Campaigns to reduce stigma and raise awareness
  • Inform people about available therapies and access to care pathways
  • Build peer support networks against isolation
  • Take the data to institutional tables: this survey is a tool

Pain can be seen. Now.

1,267 people have spoken. The data is here. The next move is up to the system.

1,267questionnaires
12associations
20regions
10MItalians
~€72bnsystem cost

For associations and institutions

Download the full results report

All the survey's evidence in a single document, ready to share and to bring to institutional tables. The report is in Italian.

Download the report (PDF, Italian)

PDF · 4 MB · in Italian

Privacy notice: the data collected is anonymous and aggregated. No personally identifiable information was requested. The results are used exclusively for the Alliance's institutional advocacy, in line with the GDPR.